CYNTHIA KLINE: Open Payments
NPI 1043601347 · HAGERSTOWN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,039 in 44 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $21 · 2025 $1,039
Food & beverage: $1,039
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $178 |
| Axsome Therapeutics, Inc. | 3 | $146 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $117 |
| Alkermes, Inc. | 4 | $115 |
| Corium, LLC | 4 | $101 |
| Vanda Pharmaceuticals Inc. | 2 | $58 |
| Otsuka America Pharmaceutical, Inc. | 3 | $52 |
| E.R. Squibb & Sons, L.L.C. | 3 | $50 |
| Collegium Pharmaceutical, Inc. | 2 | $42 |
| TMS NeuroHealth Centers Inc. | 1 | $40 |
Products named: VRAYLAR, Auvelity, CAPLYTA, ARISTADA, Azstarys, FANAPT, ABILIFY ASIMTUFII, COBENFY.
Industry payments across MD — which companies pay providers there.
